Physician profile
David Lawrence
NPI 1891729976
$1,454.18
in general payments reported to CMS, 2019-2025
13 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $17.15 · 2021: $426 · 2022: $75.49 · 2023: $329 · 2024: $95.09 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gramercy Extremity Orthopedics LLC | $415.41 | 2021-2023 | |
| Polynovo North America LLC | $193.53 | 2025 | Novosorb Btm |
| Stryker Corporation | $165.82 | 2021-2023 | Ortholoc 2 Lapifuse |
| Wright Medical Technology, INC. | $132.12 | 2019 | |
| Misonix INC | $131.94 | 2021 | |
| Horizon Therapeutics Plc | $112.05 | 2019 | |
| Smith+Nephew, INC. | $86.76 | 2020-2024 | Stravix |
| Paratek Pharmaceuticals, INC. | $86.55 | 2024-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $47.50 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $28.86 | 2022 | |
| Zimmer Biomet Holdings, INC. | $22.97 | 2022 | |
| Kci USA, INC. | $19.36 | 2023 | Promogran Prisma, 3m Coban, V.A.C. Dermatac |
| Merck Sharp & Dohme LLC | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.